ID: ALA447414

Max Phase: Preclinical

Molecular Formula: C19H22K2NO5P

Molecular Weight: 377.38

Molecule Type: Small molecule

Representations

Canonical SMILES:  CC(C)(C(=O)NCCCc1cccc(Oc2ccccc2)c1)P(=O)([O-])[O-].[K+].[K+]

Standard InChI:  InChI=1S/C19H24NO5P.2K/c1-19(2,26(22,23)24)18(21)20-13-7-9-15-8-6-12-17(14-15)25-16-10-4-3-5-11-16;;/h3-6,8,10-12,14H,7,9,13H2,1-2H3,(H,20,21)(H2,22,23,24);;/q;2*+1/p-2

Standard InChI Key:  RJZOFKGKBUPEQY-UHFFFAOYSA-L

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 377.38

Molecular Weight (Monoisotopic): 377.1392

AlogP: 3.48

#Rotatable Bonds: 8

Polar Surface Area: 95.86

Molecular Species: ACID

HBA: 3

HBD: 3

#RO5 Violations: 0

HBA (Lipinski): 6

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 1.56

CX Basic pKa:

CX LogP: 2.51

CX LogD: 0.12

Aromatic Rings: 2

Heavy Atoms: 26

QED Weighted: 0.48

Np Likeness Score: -0.36

References

1. Song Y, Liu CI, Lin FY, No JH, Hensler M, Liu YL, Jeng WY, Low J, Liu GY, Nizet V, Wang AH, Oldfield E..  (2009)  Inhibition of staphyloxanthin virulence factor biosynthesis in Staphylococcus aureus: in vitro, in vivo, and crystallographic results.,  52  (13): [PMID:19456099] [10.1021/jm9001764]

Source

Source(1):

• Scientific Literature